OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes
Federica Perillo, Chiara Amoroso, Francesco Strati, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5389-5389
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon
Cuiling Guo, Dandan Guo, Liu Fang, et al.
Carbohydrate Polymers (2021) Vol. 267, pp. 118231-118231
Closed Access | Times Cited: 281

Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation
Olga Brusnic, Danusia Onișor, Adrian Boicean, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6578-6578
Open Access | Times Cited: 24

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
Sha Li, Jinyi Liu, Xiangjin Zheng, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 80

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
Wanru Zhang, Yaping An, Xiali Qin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 70

Therapeutic potential and nutritional significance of Ganoderma lucidum – a comprehensive review from 2010 to 2022
Mohammed Sharif Swallah, Precious Bondzie‐Quaye, Yahui Wu, et al.
Food & Function (2023) Vol. 14, Iss. 4, pp. 1812-1838
Closed Access | Times Cited: 32

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1

Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies
Jelena Popov, Valentina Caputi, Nandini Nandeesha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11365-11365
Open Access | Times Cited: 51

Antibacterial, Antiviral, Antioxidant, and Anticancer Activities of Postbiotics: A review of Mechanisms and Therapeutic Perspectives
Leili Aghebati‐Maleki, Paniz Hasannezhad, Amin Abbasi, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 2, pp. 2629-2645
Open Access | Times Cited: 49

Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity
Stefan Lozenov, Boris Krastev, Georgi Nikolaev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5978-5978
Open Access | Times Cited: 16

Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers
Federica Mascaretti, Salman Haider, Chiara Amoroso, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 2, pp. 662-678
Closed Access | Times Cited: 5

Postbiotics, Metabolic Signaling, and Cancer
Nikola Vrzáčková, Tomáš Ruml, Jaroslav Zelenka
Molecules (2021) Vol. 26, Iss. 6, pp. 1528-1528
Open Access | Times Cited: 32

Small Biological Fighters Against Cancer: Viruses, Bacteria, Archaea, Fungi, Protozoa, and Microalgae
Pathea Bruno, Peter Biggers, Niyogushima Nuru, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 665-665
Open Access

Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways
Jyoti Singh, Suaib Luqman, Abha Meena
Current Molecular Pharmacology (2022) Vol. 16, Iss. 5
Closed Access | Times Cited: 20

The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
Aldona Kasprzak, Agnieszka Geltz
Biomedicines (2024) Vol. 12, Iss. 3, pp. 578-578
Open Access | Times Cited: 4

Gut eukaryotic virome in colorectal carcinogenesis: Is that a trigger?
Luca Massimino, Sara Lovisa, Luigi Antonio Lamparelli, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 19, pp. 16-28
Open Access | Times Cited: 27

A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 3

Exploring the Relationship Between Diet, Lifestyle and Gut Microbiome in Colorectal Cancer Development: A Recent Update
Biki Saha, A T Rithi, Subhamay Adhikary, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 9, pp. 789-814
Open Access | Times Cited: 3

Microbiota-targeted therapies in inflammation resolution
Francesco Strati, Georgia Lattanzi, Chiara Amoroso, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101599-101599
Closed Access | Times Cited: 15

Correlation between the regulation of intestinal bacteriophages by green tea polyphenols and the flora diversity in SPF mice
Sashuang Dong, Zilong Xin, Wencan He, et al.
Food & Function (2022) Vol. 13, Iss. 5, pp. 2952-2965
Closed Access | Times Cited: 14

Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
Christina Thoda, Maria Touraki
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top